Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease

被引:30
作者
Moennikes, H. [1 ]
Schwan, T. [2 ]
van Rensburg, C. [3 ]
Straszak, A. [4 ]
Theek, C. [5 ]
Sander, P. [2 ]
Luehmann, R. [2 ]
机构
[1] Charite, Dept Med, Martin Luther Hosp, Acad Teaching Hosp, D-14193 Berlin, Germany
[2] Nycomed GmbH, Constance, Germany
[3] Tygerberg Acad Hosp, Cape Town, South Africa
[4] City Hosp, Dept Internal Med, Siemianowice Slaskie, Poland
[5] Pierrel Res, Essen, Germany
关键词
QUALITY-OF-LIFE; GASTROINTESTINAL DISORDERS; ENDOSCOPIC ASSESSMENT; GENERAL-POPULATION; PLACEBO-RESPONSE; GERD; IBS; METAANALYSIS; ESOPHAGITIS; PREVALENCE;
D O I
10.1111/j.1365-2036.2012.05085.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background Gastro-oesophageal reflux disease (GERD), functional dyspepsia (FD) and irritable bowel syndrome (IBS) are highly prevalent gastrointestinal conditions with accumulating evidence of overlap in patients. Despite availability of a vast body of research related to individual disorders, major pharmacological breakthrough in treatment of the overlap condition is still lacking. Aim To assess sustainability of GERD healing and whether known beneficial effects of proton pump inhibitor treatment on GERD also extend to symptoms suggestive of FD and IBS. Methods A total of 626 patients with reflux oesophagitis were treated with pantoprazole for up to 16 weeks depending on healing of GERD, followed by an observational phase of up to 6 months without treatment. Rates of patients suffering from GERD, FD or IBS were assessed at baseline, and at last visits of treatment and observational phase. Results Rates of patients with reflux oesophagitis and concomitantly with reflux symptoms, FD or IBS were each significantly lower after pantoprazole treatment (P < 0.0001). While rates of patients with reflux signs or symptoms increased again during observational phase, rates of FD and IBS were maintained at the low level after cessation of medication (P < 0.0001). Conclusions Pantoprazole is efficacious in the treatment of patients suffering from signs and symptoms suggesting an overlap of GERD, FD and/or IBS, providing a sustained response post-treatment in FD and IBS symptom categories. Mechanisms underlying the beneficial effects of improvement in reflux oesophagitis on symptoms suggestive of FD or IBS still need to be determined.
引用
收藏
页码:1279 / 1289
页数:11
相关论文
共 45 条
[1]
IRRITABLE-BOWEL-SYNDROME AND DYSPEPSIA IN THE GENERAL-POPULATION - OVERLAP AND LACK OF STABILITY OVER TIME [J].
AGREUS, L ;
SVARDSUDD, K ;
NYREN, O ;
TIBBLIN, G .
GASTROENTEROLOGY, 1995, 109 (03) :671-680
[2]
The endoscopic assessment of esophagitis: A progress report on observer agreement [J].
Armstrong, D ;
Bennett, JR ;
Blum, AL ;
Dent, J ;
deDombal, FT ;
Galmiche, JP ;
Lundell, L ;
Margulies, M ;
Richter, JE ;
Spechler, SJ ;
Tytgat, GNJ ;
Wallin, L .
GASTROENTEROLOGY, 1996, 111 (01) :85-92
[3]
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - Update 2004 [J].
Armstrong, D ;
Marshall, JK ;
Chiba, N ;
Enns, R ;
Fallone, CA ;
Fass, R ;
Hollingworth, R ;
Hunt, RH ;
Kahrilas, PJ ;
Mayrand, S ;
Moayyedi, P ;
Paterson, WG ;
Sadowski, D ;
van Zanten, SJV .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (01) :15-35
[4]
Do gastrointestinal symptoms fluctuate in the short-term perspective?: The Kalixanda study [J].
Bolling-Sternevald, E. ;
Aro, P. ;
Ronkainen, J. ;
Storskrubb, T. ;
Talley, N. J. ;
Junghard, O. ;
Agreus, L. .
DIGESTIVE DISEASES, 2008, 26 (03) :256-263
[5]
Pantoprazole - An update of its pharmacological properties and therapeutic use in the management of acid-related disorders [J].
Cheer, SM ;
Prakash, A ;
Faulds, D ;
Lamb, HM .
DRUGS, 2003, 63 (01) :101-132
[6]
Do distinct dyspepsia subgroups exist in the community? A population-based study [J].
Choung, Rok Seon ;
Locke, G. Richard, III ;
Schleck, Cathy. D. ;
Zinsmeister, Alan R. ;
Talley, Nicholas J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (09) :1983-1989
[7]
Gastroesophageal reflux disease and irritable bowel syndrome: A common overlap syndrome [J].
Dickman R. ;
Feroze H. ;
Fass R. .
Current Gastroenterology Reports, 2006, 8 (4) :261-265
[8]
Drossman DA, 1999, GUT, V45, P1
[9]
The functional gastrointestinal disorders and the Rome III process [J].
Drossman, Douglas A. .
GASTROENTEROLOGY, 2006, 130 (05) :1377-1390
[10]
Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease [J].
Fass, Ronnie .
DRUGS, 2007, 67 (11) :1521-1530